<rss version="2.0">
	<channel>
		<title>Frédéric Joliot Institute for Life Sciences - On the same theme</title>
		<link>https://joliot.cea.fr/drf/joliot/en/Pages/ARCHIVES/IBITECS_anglais/News/2013/Lynch-Syndrome-structural-biology-in-the-service-of-diagnostic-support.aspx</link>
		<description>Website of the Frédéric-Joliot Institute of Life Sciences which includes 4 departments: I2BC, DMTS, NeuroSpin and Service hospitalier Frédéric Joliot (SHFJ). The teams are mainly located at the CEA Paris-Saclay center and at the Orsay hospital. </description>
		<language>en-US</language>
		<image>
			<url>https://www.cea.fr/Style%20Library/Themes/drf/instituts/images/logo-cea-joliot-2023.png</url>
			<title>Frédéric Joliot Institute for Life Sciences - On the same theme</title>
			<link>https://joliot.cea.fr/drf/joliot/en</link>
		</image>

			<item>
				<title>Toward CAR-macrophage-based cellular immunotherapy for treating certain solid tumors?</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2026/CAR-macrophages-cancers-solides.aspx</link>
				<description>Researchers from our DMTS department have published a study providing the first proof of concept for a CAR-macrophage therapy targeting the endothelin B receptor, which is overexpressed in melanoma cells.</description>
				<category domain="thematiques">Immune system ; Cancer ; Diagnosis and innovative treatment</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SPI</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 09 Mar 2026 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2026/GettyImages-1317697228-vignette.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Seismic-wave physics for diagnosing brain tumors with passive MRI elastography</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/Cerebral-tumour-diagnosis-passive-elastography.aspx</link>
				<description>Researchers at SHFJ and NeuroSpin applied a passive MRI elastography sequence to patients with brain tumors. This non-invasive approach provided information on tumor stiffness and nature, and could support early detection, surgical planning, and treatment monitoring.</description>
				<category domain="thematiques">Medical imaging ; MRI ; Cancer ; Brain</category>
				<category domain="public"></category>
				<category domain="organisation">Neurospin</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Wed, 26 Nov 2025 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/Gennisson-pMRE-Vignette.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>A mechanism protecting telomeres against chromosomal fusions</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/Protection-telomeres-fusions-chromosomiques.aspx</link>
				<description>Researchers from CEA-Jacob and the Genome Integrity team at I2BC, in collaboration with Gustave Roussy and the Institut Pasteur, demonstrate that the Rap1 protein prevents the translocation of the Ku protein— a major factor in double-strand break repair — thereby avoiding deleterious fusions between chromosomes. </description>
				<category domain="thematiques">Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">microscopie électronique;</category>
				<pubDate>Mon, 17 Nov 2025 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/Ku-Rap1-DNA-vignette.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Proof of concept for the passage of trastuzumab formulated in nanoparticles through an in vitro-reconstituted nasal epithelium.</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/Transport-trastuzumab-nanoparticles-nasal-epithelium.aspx</link>
				<description>​Researchers from SPI (DMTS) developed a formulation of PLGA nanoparticles loaded with the anticancer trastuzumab (NP-TZB) and measured their ability to cross a cellular model of the nasal epithelial barrier. This first validated step supports a potential nose-to-brain (N2B) delivery route.</description>
				<category domain="thematiques">Nanomedicine ; Cancer ; Pharmacology</category>
				<category domain="public"></category>
				<category domain="organisation">SPI</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Wed, 12 Nov 2025 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/NP-PLGA-Vignette.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Cyanine 5-huwentoxin-IV : a new imaging agent for non-small cell lung cancer ?</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/Cyanine-5-huwentoxin-IV-imaging-agent-lung-cancer.aspx</link>
				<description>A team from SIMoS (DMTS) has demonstrated the ability of a peptide derived from a spider venom toxin to detect overexpressed sodium channels in a metastatic non-small cell lung cancer (NSCLC) cell line.</description>
				<category domain="thematiques">Biotechnology ; Biomarkers ; Cell and molecular imaging ; Cancer</category>
				<category domain="public"></category>
				<category domain="organisation">SIMOPRO</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 10 Nov 2025 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/Servent-Huwentoxin-Vignette.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Mitosis: condense to better attach</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/Mitose-KIF2C.aspx</link>
				<description>A study led by the I2BC shows that the formation of condensates of the enzyme KIF2C enables the concentration of two other proteins, PLK1 and phosphorylated BRCA2, on kinetochore microtubules during mitosis. This would serve to control chromosome alignment on the spindle and contribute to their stability.</description>
				<category domain="thematiques">DNA ; Structural biology ; Cancer</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 08 Sep 2025 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/KIF2-Kinetochore.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Grâce à de petits motifs dans une séquence désordonnée, Rad52 organise l’assemblage de Rad51</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/Sequence-desordonnee-Rad52-assemblage-Rad51.aspx</link>
				<description>En utilisant Saccharomyces cerevisiae comme modèle, des chercheurs des instituts CEA-Jacob et CEA-Joliot, et de l’Institut Curie, avec leurs partenaires du synchrotron SOLEIL, ont révélé comment la protéine Rad52 agit comme un chaperon pour guider et stabiliser l’assemblage de Rad51, une étape clé de la recombinaison homologue.​</description>
				<category domain="thematiques">Structural biology ; Cellular mechanisms ; Molecular mechanisms</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 28 Jul 2025 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/Rad51-52_Poulpe-RGuerois-vignette.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Cancer : transformer la mertansine en prodrogue pour une chimiothérapie ciblée et moins toxique grâce à une approche théranostique.</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/Cancer-mertansine-prodrogue.aspx</link>
				<description>Une équipe du laboratoire BioMaps, en collaboration avec l’Institut Galien Paris-Saclay a mis au point une stratégie innovante associant une prodrogue polymère et l&apos;imagerie par tomographie par émission de positons (TEP) pour améliorer l&apos;efficacité de la mertansine, un agent antitumoral puissant mais toxique. </description>
				<category domain="thematiques">Medical imaging ; Diagnosis and innovative treatment ; Cancer</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SHFJ</category>
				<category domain="typologie">Scientific result ; Article</category>
				<category domain="keywords">préclinique;modèle animal;</category>
				<pubDate>Tue, 01 Jul 2025 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/Mertansine-figure.png?RenditionID=6" type="image/png"></enclosure>
			</item>

			<item>
				<title>Computational modeling reveals the nature of human alpha-synuclein interactions with polyethylene nanoplastics</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/Interactions-of-alpha-synuclein-with-polyethylene-nanoplastics.aspx</link>
				<description>A team from I2BC, in collaboration with the NIMBE (CEA-Iramis), is unveiling the nature of the interactions of human alpha-synuclein (hαSn) with polyethylene nanoplastics, using molecular dynamics simulations and experimental methods. </description>
				<category domain="thematiques">Nanotoxicology ; Simulation ＆ modelling ; Structural biology</category>
				<category domain="public"></category>
				<category domain="organisation">Iramis</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Tue, 27 May 2025 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/Boulard-Vignette.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Theranostic antibodies targeting endothelin receptors in preclinical models of glioblastoma and melanoma</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/Theranostic-antibodies-endothelin-receptors-models-glioblastoma-melanoma.aspx</link>
				<description>Researchers from SPI (DMTS) propose immunodiagnostic and immunotherapeutic approaches based on the use of innovative antibodies targeting two subtypes of endothelin receptors (ETA and ETB), recognised as relevant therapeutic targets in oncology.</description>
				<category domain="thematiques">Health ＆ life sciences ; Cancer ; Medical imaging ; Positron Emission Tomography</category>
				<category domain="public"></category>
				<category domain="organisation">Neurospin</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">preclinical research;animal models;</category>
				<pubDate>Thu, 22 May 2025 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/Boquet-Truillet-Vignette.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Quand les interfaces protéine-ARN se réinventent : une conservation globale avec une pointe de versatilité !</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/interfaces-proteine-ARN.aspx</link>
				<description>Une équipe de l’I2BC a mené une étude prédictive de la structure des interfaces d’interaction dans les complexes protéine - ARN : bien que de nombreux aspects de ces interfaces soient largement conservés au cours de l’évolution, une grande versatilité existe dans les contacts polaires entre les molécules.</description>
				<category domain="thematiques">Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Tue, 20 May 2025 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/Protein-ARN-interaction-vignette.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Synthesis of an anti-cancer drug in living cells using micelle-based nanoreactors</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/Synthesis-anti-cancer-drug-cells-using-nanomicelles.aspx</link>
				<description>A team at SCBM (DMTS) has designed nanomicelles that can be activated by a bioorthogonal reaction releasing a first chemical species, which then reacts with a second compound encapsulated in the micelles. Application to the synthesis of an anti-cancer drug, sorafenib, inside living cells. </description>
				<category domain="thematiques">Chemistry ; Methodologies for life sciences ; Cancer</category>
				<category domain="public"></category>
				<category domain="organisation">SCBM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Fri, 11 Apr 2025 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/Taran-Angew-Nanoreactor-Vignette.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Immunological profiling of cancer : when click-chemistry meets mass spectrometry</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2025/Cancer-immunoprofiling-click-chemistry-mass-spectrometry.aspx</link>
				<description>Researchers at DMTS and SHFJ have carried out a multiplexed analysis of tumor cells and tissues, based on the use of cleavable therapeutic antibodies carrying mass tags, for the identification and quantification of cancer biomarkers. A proof-of-concept demonstrating the high potential of this tumor immunoprofiling approach</description>
				<category domain="thematiques">Cancer ; Chemistry ; Mass spectrometry ; Diagnosis</category>
				<category domain="public"></category>
				<category domain="organisation">SIMOPRO</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">preclinical research;animal models;</category>
				<pubDate>Mon, 13 Jan 2025 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2025/Taran-ChemSci-Vignette.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Immunothérapie anticancéreuse : un modèle structural pour comprendre l’action synergique de deux anticorps thérapeutiques sur la cible HER2</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2024/Immunotherapie-structure-HER2-trastuzumab-pertuzumab.aspx</link>
				<description>Des chercheurs de l’I2BC, en collaboration avec Sanofi, l’IMPMC et l’Institut Pasteur, ont modélisé la structure du complexe associant le récepteur membranaire HER2 avec deux fragments de liaison (Fab) de deux anticorps thérapeutiques dirigés contre cette cible, le trastuzumab et le pertuzumab. </description>
				<category domain="thematiques">Structural biology ; Microscope</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Fri, 08 Nov 2024 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2024/HER2-trastuzumab-pertuzumab-imagette.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Micelles : comment améliorer l’efficacité radiothérapeutique lorsque les tumeurs résistent ?</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2024/Micelles-efficacite-radiotherapeutique-tumeurs-radioresistantes.aspx</link>
				<description>​Des équipes du SCBM et du SHFJ, en collaboration avec le CEA-Jacob et l’ISMO ont développé une micelle perfluorée biocompatible pour améliorer l’efficacité des radiothérapies et qui serait particulièrement intéressante dans des environnements tumoraux radiorésistants.</description>
				<category domain="thematiques">Diagnosis and innovative treatment ; Cancer</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SCBM</category>
				<category domain="typologie">Scientific result ; Article</category>
				<category domain="keywords">Cancer;préclinique;théranostique;modèle animal;</category>
				<pubDate>Wed, 23 Oct 2024 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2024/Micelles_carrousel_Godel-Pastre.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>The structure of the transmembrane region of the SARS-CoV-2 nsp3 protein confirms its essential role in viral replication</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2024/Structure-transmembrane-region-SARS-CoV-2-nsp3-protein.aspx</link>
				<description>An I2BC team has revealed the structure of the C-terminal transmembrane region of the SARS-CoV-2 protein nsp3, essential for virus replication. This region self-assembles into hexamers that form molecular pores on the surface of double-membrane vesicles, the sites of viral genome replication. Nsp3 therefore appears to be a promising therapeutic target.</description>
				<category domain="thematiques">Structural biology ; Virus</category>
				<category domain="public"></category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Thu, 08 Aug 2024 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2024/Gervais-JVirol-Vignette.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>DNA recombination: AlphaFold2 breaks a lock</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2024/DNA-recombination-lock.aspx</link>
				<description>Teams from I2BC, Institut Curie and IRB shed light on how the human nuclease MRN works. Structural predictions obtained with AlphaFold2 and confirmed by in vitro and in vivo experiments show that the phosphorylated Sae2/CtIP protein forms a network of interactions with MRN that favours the removal of its autoinhibition.</description>
				<category domain="thematiques">Structural biology ; DNA ; Molecular mechanisms ; Artificial intelligence</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Tue, 25 Jun 2024 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2024/MRN-AlphaFold2.png?RenditionID=6" type="image/png"></enclosure>
			</item>

			<item>
				<title>Insight into the activation process of MCM8-MCM9 Helicases</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2024/HROB-MCM8-MCM9.aspx</link>
				<description>Researchers from the AMIG team (I2BC department), in collaboration with the IRB (Switzerland), have modeled the interaction between HROB and the helicases MCM8-MCM9, some mutations of which predispose individuals to infertility or cancer. They demonstrate that HROB promotes the catalytic activity of the MCM8-MCM9 complex but does not play a role in its recruitment or stability.</description>
				<category domain="thematiques">Structural biology ; Molecular mechanisms</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result ; Article</category>
				<category domain="keywords">AlphaFold;AlphaFold2;</category>
				<pubDate>Wed, 22 May 2024 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2024/HROB-figure.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Response to intra-tumoral immunotherapy assessed by immunoPET in mice</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2024/Response-intra-tumoral-immunotherapy-by-immunoPET.aspx</link>
				<description>A team from BioMaps (SHFJ), in partnership with the Gustave Roussy Institute, has used immunoPET imaging to assess the influence of tissue distribution on the efficacy of cancer immunotherapy, administered intra-tumor and intravenously in mice. Intratumoral administration is more effective and reduces overall exposure of organs at risk</description>
				<category domain="thematiques">Medical imaging ; Positron Emission Tomography ; Cancer</category>
				<category domain="public"></category>
				<category domain="organisation">SHFJ</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">preclinical research;animal models;</category>
				<pubDate>Fri, 19 Apr 2024 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2024/Truillet-Vignette-bis.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Epigenetics: combining flexible and rigid regions in a single structure to guarantee genome replication and stability</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2024/Epigenetics-CAF-1.aspx</link>
				<description>A team from the I2BC, in collaboration with the Institut Curie and Soleil, has shown that the CAF-1 protein combines flexible regions and rigid modules in its spatial organisation to deposit histones on DNA and effectively couple this process to DNA synthesis.</description>
				<category domain="thematiques">Epigenetics ; Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result ; Article</category>
				<category domain="keywords"></category>
				<pubDate>Tue, 26 Mar 2024 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2024/CAF-1-epigenetique.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Cryo-EM : A ring-shaped organisation for better control of the local concentration of BRCA2 essential for homologous recombination</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2024/Cryo-EM-ring-BRCA2-HSF2BP.aspx</link>
				<description>A collaboration involving the I2BC has modelled the structure of the complex between HSF2BP and a fragment of BRCA2, which is essential for DNA repair by homologous recombination. The researchers propose a mechanism for regulating the unexpected ring-like assembly of this complex. </description>
				<category domain="thematiques">Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result ; Article</category>
				<category domain="keywords"></category>
				<pubDate>Thu, 08 Feb 2024 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2024/BRCA2-HSF2BP.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Protein-protein interactions: how to push forward the limits of the revolutionary AlphaFold2 programme?</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2024/proteins-proteins-interactions-AlphaFold2.aspx</link>
				<description>In an article published in Nature Communications, researchers from the I2BC show that applying a fragmentation strategy to the protein partners of assemblies depending on intrinsically disordered regions very significantly improves AlphaFold2&apos;s prediction capacity.</description>
				<category domain="thematiques">Structural biology ; Artificial intelligence</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 29 Jan 2024 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2024/AlphaFold2-Spaghettis-RGuerois-CEA-BD.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Phytic acid: a small molecule that helps repair DNA breaks</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2023/phytic-acid-DNA-repair.aspx</link>
				<description>In an article published in the journal Nucleic Acids Research, scientists from the I2BC, lPBS and the Institute for Structural and Chemical Biology (University of Leicester, UK) demonstrate how phytic acid, a product of cellular metabolism, stabilises the assembly of a complex enabling the repair of DNA breaks in humans.</description>
				<category domain="thematiques">DNA ; Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result ; Article</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 04 Dec 2023 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2023/AcidePhytique_GettyImages-1329480731_vignette.jpg" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Multiplier les chimères pour mieux comprendre les interactions inhibiteur-cible protéique</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2023/Multiplier-chimeres-mieux-comprendre-interactions-inhibiteur-cible-proteique.aspx</link>
				<description>En substituant des segments d’hélice alpha​ par des segments d’oligo-urées dans un peptide inhibiteur d’ASF1, lui conférant ainsi une résistance accrue aux protéases, des chercheurs de l’I2BC en collaboration avec l’IECB explorent les modes de liaison de ces chimères peptide-urée à leur cible.</description>
				<category domain="thematiques">Molecular mechanisms ; Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result ; Article</category>
				<category domain="keywords"></category>
				<pubDate>Tue, 12 Sep 2023 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2023/ASF1-Chimera.jpg" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>PET imaging monitoring of an antibody targeting endothelin receptors expressed by glioblastoma tumors</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2023/PET-imaging-antibody-endothelin-receptors-glioblastoma-tumors.aspx</link>
				<description>Researchers at BioMaps (SHFJ) and SPI (DMTS) have studied the pharmacokinetics of a novel immuno-radioligand targeting the endothelin A receptor (ETA), overexpressed in many cancers, particularly glioblastoma. The immunoPET imaging approach used in this study in a preclinical model confirms the theranostic potential of this antibody.</description>
				<category domain="thematiques">Positron Emission Tomography ; Cancer ; Medical imaging</category>
				<category domain="public"></category>
				<category domain="organisation">Neurospin</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Thu, 07 Sep 2023 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2023/TruilletBoquet-Vignette.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Identification of metabolomic signatures of high-grade breast tumors</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2023/Metabolomic-signatures-high-grade-breast-tumors.aspx</link>
				<description>The TIRO laboratory of the SHFJ (Nice) identifies for the first time discriminating biomarkers of high-grade invasive breast tumors, using a non-targeted metabolomics approach performed on surgical specimens and cytoponctions from patients at different stages of malignancy.</description>
				<category domain="thematiques">Metabolomics ; Cancer ; Biomarkers</category>
				<category domain="public"></category>
				<category domain="organisation">SHFJ</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Fri, 04 Aug 2023 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2023/Pourcher-Vignette-CreativeDesignArt%20by%20GettyImages.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>DNA repair machinery more flexible thanks to PAXX?</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2023/Reparation-ADN-PAXX.aspx</link>
				<description>An international collaboration led by researchers from I2BC/CEA-Joliot and IPBS (Toulouse) has solved the atomic structure of molecular assemblies involved in the repair of DNA double-strand breaks. The diversity of assemblies involving the PAXX protein identified in this study highlights the great flexibility of the repair machinery, which could reflect its ability to adapt to biological conditions. The results were published in Science Advances.</description>
				<category domain="thematiques">Structural biology ; Molecular mechanisms</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">cryoEM;radiocristallographie;</category>
				<pubDate>Tue, 06 Jun 2023 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2023/KuPAXX_Vignette.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Radiomarquage du crizotinib au fluor-18 : un nouvel outil pour suivre par TEP la biodistribution de ce médicament</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2023/Radiomarquage-crizotinib-fluor-18-nouvel-outil-TEP.aspx</link>
				<description>Des chercheurs du SHFJ ont mis au point la radiosynthèse au fluor-18 du crizotinib, un médicament qui ne pénètre pas dans le cerveau. Ce nouvel outil pour l’imagerie TEP permettra d’explorer de futures stratégies visant à faire passer la barrière hémato-encéphalique à ce médicament pour traiter certaines métastases cérébrales. </description>
				<category domain="thematiques">Positron Emission Tomography ; Cancer ; Diagnosis and innovative treatment</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SHFJ</category>
				<category domain="typologie">Scientific result ; Article</category>
				<category domain="keywords"></category>
				<pubDate>Thu, 27 Apr 2023 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2023/Crizotinib-TEP-invivo.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Hepatitis E virus: AlphaFold to the rescue to better understand how this pathogen multiplies its genome</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2023/Virus-hepatite-E-AlphaFold.aspx</link>
				<description>I2BC researchers unveil an atomic model of the hepatitis E virus replication polyprotein obtained with the AlphaFold artificial intelligence program. The model provides a better understanding of how this RNA virus multiplies its genome in infected cells. </description>
				<category domain="thematiques">Structural biology ; Simulation ＆ modelling ; Artificial intelligence</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">AlphaFold2;RNA virus;in vitro translation;</category>
				<pubDate>Wed, 08 Feb 2023 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2023/VHE_vignette.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Numerical simulation provides information on the restriction of BAF protein dynamics by phosphorylation</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2023/BAF-numerical-simulation-phosphorylation.aspx</link>
				<description>Using molecular dynamics simulation and NMR studies, I2BC researchers detail the restriction mechanisms of BAF protein dynamics due to its phosphorylation.</description>
				<category domain="thematiques">Molecular mechanisms ; Structural biology ; Simulation ＆ modelling</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 16 Jan 2023 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Institut/2023/BAF_dynMol_vignette.jpg" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Towards understanding the mechanisms responsible for intrahepatic cholestasis: biochemical and structural study of the human ATPase ATP8B1</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2022/Intrahepatic-cholestasis-biochemistry-structure-ATP8B1.aspx</link>
				<description>A collaborative study involving an I2BC team unveils the mechanism of autoinhibition of the human flippase ATP8B1, as well as its regulation by lipids and phosphorylation. The study provides a better understanding of the impact of flippase mutations responsible for intrahepatic cholestasis on its enzymatic activity. </description>
				<category domain="thematiques">Molecular mechanisms ; Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">ATP;hydrolyse;protéine membranaire;modifications post-traductionnelles;expression hétérologue;membranes;cryo-EM;</category>
				<pubDate>Thu, 09 Jun 2022 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2022/Flippase_Vignette.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>New radioligands for anti-PD-1/PD-L1 immunoPET </title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2022/Radioligands-immunoPET-PD-1-PD-L1.aspx</link>
				<description>Researchers from the SHFJ and the DMTS have developed optimized radioligands for immunoPET imaging. The objective is to better predict the effectiveness of anti-PD1/anti-PDL1 immunotherapy used to fight certain cancers. </description>
				<category domain="thematiques">Positron Emission Tomography ; Cancer</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SIMOPRO</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">programmed cell death-ligand 1;</category>
				<pubDate>Tue, 12 Apr 2022 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2022/vignette_immunoTEP.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Inhibiting autophagy: a new line to fight cellular senescence?</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2022/Autophagy-senescence.aspx</link>
				<description>Researchers from the Frédéric Joliot Institute have identified ouabain and chloroquine as two selective senolytic molecules that are effective in eliminating certain senescent cells. The study has been published in the journal Aging Cell.</description>
				<category domain="thematiques">Cancer ; Cellular mechanisms</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SCBM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Tue, 15 Mar 2022 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2022/Strophanthus_gratus_Vignette_Tatiana-Gerus.jpg" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>The unveiling of atomic structure of lanreotide nanotubes surprises!</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2022/structure-nanotubes-lanreotide.aspx</link>
				<description>​Thanks to recent developments in cryo-electron microscopy, a study led by a team from the I2BC reveals, at the atomic scale, the unsuspected structural complexity of lanreotide nanotubes, a drug used in the treatment of acromegaly and some neuro-endocrine cancers. </description>
				<category domain="thematiques">Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Thu, 20 Jan 2022 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2022/Nanotube-Lanreotide-MPaternostre-CNRS-vignette.jpg" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>In silico modelling unveils mechanisms of coordination between pairing and crossovers during meiosis</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2022/Modeling-pairing-crossover-meiosis.aspx</link>
				<description>In a study conducted by a team from the Institut Curie, researchers from the CEA-Joliot (B3S/I2BC department) have modeled in silico protein-protein interactions and thus contributed to establish at the molecular level the mechanisms that coordinate the pairing and recombination of homologous chromosomes during meiosis. </description>
				<category domain="thematiques">Simulation ＆ modelling ; Structural biology ; Molecular mechanisms</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Article ; Scientific result</category>
				<category domain="keywords">recombinaison homologue;AlphaFold;crossing-over;InterEvDock3;</category>
				<pubDate>Thu, 13 Jan 2022 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2022/Ecm11_vignette.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Multiparametric PET-MRI imaging: toward a biological characterization of tumors at the supervoxel level</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2021/PET-MRI-imaging-tumors-supervoxel-level.aspx</link>
				<description>A collaborative study led by BioMaps researchers (SHFJ) demonstrates that fully integrated quantitative multiparametric  analysis of non-small cell lung cancer in hybrid 18F-FDG PET/MRI 3T imaging is clinically feasible and could enable biological characterization of tumors at the supervoxel scale. </description>
				<category domain="thematiques">Medical imaging ; Positron Emission Tomography ; MRI ; Cancer</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Wed, 10 Nov 2021 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2021/Vignette-Besson-TEP-IRM.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>The european PPI4HPC project echoes high-performance computing at CEA for the modelisation of complex molecular assemblages</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Institute/2021/High-performance-computing-molecular-modelisation.aspx</link>
				<description>A project at the interface between quantum chemistry and molecular dynamics for the study of complex molecular assemblies, led by Michel Masella (Joliot) and Luigi Genovese (IRIG), makes it possible, for applications in biology/health, to take full advantage of the new supercomputers of the Public Procurement of Innovations for High-Performance Computing (PPI4HPC, H2020) project hosted at the Très Grand Centre de Calcul (TGCC) of the CEA-Bruyères-le-Châtel.</description>
				<category domain="thematiques">Computing ; Simulation ＆ modelling ; Supercomputers ; Structural biology</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">News ; Article</category>
				<category domain="keywords"></category>
				<pubDate>Tue, 14 Sep 2021 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_institutionnelles/2021/Vignette-SuperCalculateur-JC-TGCC.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Structure of the BRCA2-HFS2BP complex: the interaction is not required for Rad51 recruitment to DNA in meiosis</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2021/BRCA2-HFS2BP-meiosis.aspx</link>
				<description>By solving the three-dimensional structure of a fragment of the BRCA2-HSF2BP complex, a collaboration involving teams from I2BC and ERASMUS MC identifies the precise BRCA2 motif that causes the very high affinity between the two partners and shows that, in vivo, this complex has no function in the recruitment of Rad51 to meiotic sites of homologous recombination. </description>
				<category domain="thematiques">Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Article ; Scientific result</category>
				<category domain="keywords">RMN;radiocristallographie;</category>
				<pubDate>Mon, 13 Sep 2021 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2021/BRCA2-HFS2BP.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>3rd version of the InterEvDock server: better exploiting protein sequence evolution data to improving the prediction of interface structures</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2021/InterEvDock3.aspx</link>
				<description>Researchers at I2BC/CEA-Joliot, in collaboration with the RPBS platform, have developed the third version of their InterEvDock server for structural modelling of protein-protein interactions. The server integrates new algorithms for exploiting sequence evolution information.</description>
				<category domain="thematiques">Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">HADDOCK;FRODOCK;coMSAs;CAPRI;</category>
				<pubDate>Mon, 21 Jun 2021 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2021/AndreaniGuerois.jpg?RenditionID=6" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Molecular basis of the “scissors” mechanism involved in meiotic recombination and DNA repair</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2021/Mlh1-Mlh3.aspx</link>
				<description>Researchers from I2BC/CEA-Joliot in collaboration with teams from Institut Curie and IRCM/CEA-Jacob, lay the molecular basis to explain the dual role of the Mlh1-Mlh3 complex in DNA mismatch repair and, quite uniquely, in one of the key steps of genetic mixing during meiosis. </description>
				<category domain="thematiques">Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">cristallography;repair;recombination;</category>
				<pubDate>Mon, 07 Jun 2021 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2021/Mlh1-Mlh3-vignette.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Phosphorylation of BAF alters its dynamics and interaction with DNA but not its contacts with the nuclear envelope</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2021/phosphorylation-BAF-interaction.aspx</link>
				<description>​A study by researchers from I2BC department shows in vitro the effect of mitotic phosphorylation of the BAF protein on its structure and its interactions with DNA and lamina and unveils consequences on genome organization and on mechanisms responsible for progeroid syndromes.</description>
				<category domain="thematiques">Molecular mechanisms ; DNA ; Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">NMR;radiocristallography;</category>
				<pubDate>Mon, 29 Mar 2021 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2021/BAF_Complex_MHLeDu.png?RenditionID=6" type="image/png"></enclosure>
			</item>

			<item>
				<title>Anti-cancer therapeutic strategy: a chimera to inhibit ASF1</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2021/Foldamer-inhibitor-ASF1.aspx</link>
				<description>I2BC researchers, in collaboration with the European Institute of Chemistry and Biology (University of Bordeaux, CNRS), have developed a chimeric peptide/foldamer molecule that is resistant to proteolysis and inhibits ASF1, a potential target for anticancer treatment. The resolution of the structure of this chimera in interaction with its target, the first of its kind, reveals an unsuspected plasticity of the urea-based backbone that hugs the surface of ASF1. </description>
				<category domain="thematiques">Structural biology ; Molecular mechanisms ; Epigenetics ; Cancer</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">NMR;radiocristallography;</category>
				<pubDate>Fri, 19 Mar 2021 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Science/2021/Asf1-ChimericInhibitor-vignette.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>First functional characterization of ATP2, an essential Plasmodium flippase and potential antimalarial target</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2021/Functional-characterization-PcATP2-essential-Plasmodium-flippase.aspx</link>
				<description>I2BC researchers, in collaboration with the Autonomous University of Barcelona, have provided the first studies of the function and structural organization of a flippase encoded by a parasite responsible for malaria, a first step towards understanding the essential physiological function of this transporter and its potential use as an antimalarial target.</description>
				<category domain="thematiques">Structural biology ; Infectious diseases</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Wed, 17 Mar 2021 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2021/Vignette-rbcs-P-chabaudi.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>A micellar probe for fluorine magnetic resonance tumor imaging</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2021/Micellar-probe-fluorine-MRI-tumor.aspx</link>
				<description>A SCBM (DMTS) team, in collaboration with researchers at NeuroSpin and I2BC, is describing micellar nanometric vectors targeting tumors that have been imaged by fluorine magnetic resonance imaging (MRI). The observed 19F signal made it possible to precisely delimit the volume of the tumor zone in a mouse model and to quantify the probe accumulated in the target tissue.</description>
				<category domain="thematiques">Chemistry ; Nanomedicine ; Cancer ; MRI</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Thu, 04 Mar 2021 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2021/Vignette-micelle-fluor-Ang.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Permeabilizing the blood-brain barrier to deliver therapeutic antibodies into the brain? ImmunoPET imaging provides answers</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2020/ImmunoPET-BBB-Ab.aspx</link>
				<description>Researchers from SHFJ, NeuroSpin and DMTS have demonstrated, by immunoPET imaging, the impact of transient BBB permeabilization on brain exposure to an anti-EGFR antibody. Promising prospects for targeted immunotherapy of glioblastoma.</description>
				<category domain="thematiques">Cancer ; Medical imaging ; Positron Emission Tomography</category>
				<category domain="public"></category>
				<category domain="organisation">SIMOPRO</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">radiomarquage;zirconium;IRM;</category>
				<pubDate>Tue, 06 Oct 2020 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2020/Truillet_ImmunoTEP-AcEGFR_vignette.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Lamins and Progeria: What Does Structural Biology Tell Us?</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Institute/2020/Lamines-Progeria-Structural-Biology.aspx</link>
				<description>A team from the I2BC publishes in FEBS Journal an exhaustive review of the various mutations affecting the structure of type A lamins, proteins that make up the envelope of the cell nucleus (nuclear lamina), which lead to premature aging in people with the disease (Progeria). </description>
				<category domain="thematiques">Structural biology ; Diseases</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie"></category>
				<category domain="keywords"></category>
				<pubDate>Mon, 24 Aug 2020 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_institutionnelles/2020/Vignette-Zinn-Progeria.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>BRCA2 and breast cancer: a new mechanism revealed?</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2020/BRCA2-breast-cancer.aspx</link>
				<description>​In a study conducted by a team from the Institut Curie, I2BC researchers have used their NMR know-how to study the phosphorylation of BRCA2 and  have thus contributed to revealing a mechanism potentially at the origin of chromosomal aberrations observed in breast BRCA2-mutated tumors.</description>
				<category domain="thematiques">Molecular mechanisms ; Cancer</category>
				<category domain="public"></category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">homologous recombination;Rad51;kinase;</category>
				<pubDate>Mon, 27 Apr 2020 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2020/Vignette_CharlotteMartin_InstitutCurie.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Innovative approach to radiolabel peptides with fluorine-18 for PET imaging</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2020/Innovative-approach-radiolabel-peptides-fluorine-18-PET-imaging.aspx</link>
				<description>Radiochemists from the BioMaps unit (SHFJ) have developed and automated a new fluor-18 radiolabelling method for peptides used to characterize specific pathological molecular signatures and thus target treatments. Peptides were conjugated to a specific tag, then radiolabeled in a single step under mild conditions, making this approach an innovative solution for PET imaging of peptides labeled with fluorine-18.</description>
				<category domain="thematiques">Chemistry ; Positron Emission Tomography ; Cancer</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 17 Feb 2020 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2020/Vignette-TEP-SHFJ[1].jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Glucocorticoids: a better evaluation of their effects in specific cancers?</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2019/Glucocorticoids-better-evaluation-effect-cancers.aspx</link>
				<description>Senescence specialists (SBIGEM), in collaboration with the SCBM and the CNRGH (Jacob Institute), show that glucocorticoids can delay or even short-circuit it and disrupt its function as a tumor suppressor.</description>
				<category domain="thematiques">Cellular mechanisms ; Molecular mechanisms ; Cancer</category>
				<category domain="public"></category>
				<category domain="organisation">Fontenay-aux-Roses</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">MEK/ERK;oncogenesis;Senescence;</category>
				<pubDate>Mon, 09 Sep 2019 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2019/Melanoma_NationalCancerInstitute.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>A new biomarker to predict tumor progression from whole body PET images.</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2019/New-prediction-biomarker-tumor-progression-PET-images.aspx</link>
				<description>The SHFJ/IMIV laboratory (Inserm 1023/CNRS/CEA/UP-Sud), in collaboration with hospital-university teams, has shown that, in patients with advanced-stage large cell lymphoma (B type), automatic quantitative measurements of tumor dissemination detected by whole-body PET imaging have a predictive value of progression-free survival (tumor stabilization) and overall survival.</description>
				<category domain="thematiques">Medical imaging ; Positron Emission Tomography ; Cancer</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Tue, 16 Jul 2019 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2019/Vignette-TEP-SHFJ.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Lipid transmembrane transport: very first structures are revealed! </title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2019/Drs2-Cdc50-CryoEM-Structure-Nature.aspx</link>
				<description>Researchers from I2BC@Saclay, the University of Aarhus and the Max Planck Institute of Biophysics in Frankfurt reveals the first cryo-EM high-resolution structures of one of the P4-ATPases. Study has been published in Nature. It give a better insight towards the understanding of the transport mechanisms of membrane lipids. A lipid pathway through the protein membrane domain is suggested.   
</description>
				<category domain="thematiques">Structural biology ; Molecular mechanisms</category>
				<category domain="public"></category>
				<category domain="organisation">Saclay</category>
				<category domain="typologie">Press release ; Scientific result</category>
				<category domain="keywords">lipid asymetry;P4-ATPase;membrane lipid translocation;</category>
				<pubDate>Thu, 27 Jun 2019 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2019/Vignette_StructureDrs2-Cdc50.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>FRISBI: the structural biology platform of Genopole joins the National Infrastructure</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Institute/2019/Genopole-structural-biology-platforms-joins-FRISBI.aspx</link>
				<description>The French National Infrastructure of Integrated Structural Biology (FRISBI) is now integratinf Genopole&apos;s structural biology platform into its Paris-Sud node. </description>
				<category domain="thematiques">Structural biology</category>
				<category domain="public">Researchers</category>
				<category domain="organisation">Saclay</category>
				<category domain="typologie">Academic partnerships</category>
				<category domain="keywords">i;microscope à force atomique;plateforme;</category>
				<pubDate>Fri, 10 May 2019 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Plateformes_et_infrastructures/Les_infrastructures_nationales_biologie_sante/FRISBi/frisbi_vignette.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>« Click and Release » chemistry for the targeted delivery of drugs in vivo</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2019/Click-Release-chemistry-targeted-delivery-drug-invivo.aspx</link>
				<description>A team from the SCBM, in collaboration with the SPI, the IC2MP and the University Hospital of Poitiers, has developed a bioorthogonal chemistry strategy that allows, in vivo, the controlled release of active ingredients contained in micelles-targeting cancerous tumors. These results pave the way for new strategies for targeted drug delivery.</description>
				<category domain="thematiques">Chemistry ; Cancer ; Nanomedicine</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Fri, 15 Mar 2019 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2019/vignette%20taran.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Towards a better detection of glioblastoma infiltration</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2019/Towards-better-detection-glioblastoma-infiltration.aspx</link>
				<description>Glioblastoma is a very aggressive cancer of the central nervous system, mainly because of its ability to infiltrate the surrounding areas. A collaboration led by a team of SHFJ and involving NeuroSpin demonstrates the interest of two imaging techniques for the early detection of tumor infiltration.
</description>
				<category domain="thematiques">Cancer ; Medical imaging ; Positron Emission Tomography</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">PET imaging;glioblastoma;</category>
				<pubDate>Tue, 26 Feb 2019 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2019/Glioblastome_Inserm-Guichet_Pierre-Olivier.png" type="image/png"></enclosure>
			</item>

			<item>
				<title>Cerebral lymphoma: a new indication for [18F]Fludarabine?</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2018/TEP-18FFludarabine-lymphome-cerebral.aspx</link>
				<description>A SHFJ research team (LDM-TEP, GIP Cyceron, Caen) has previously developed and produced a radiopharmaceutical, the [18F]-Fludarabine, to detect lymphomas using PET scan. The team has recently conducted a preclinical study that shows the molecule can help in diagnosis of cerebral lymphoma by differentiate it from glioblastoma, the main brain tumor. A clinical study should be launched before the end of the year.</description>
				<category domain="thematiques">Brain ; Medical imaging ; Cancer ; Diagnosis</category>
				<category domain="public"></category>
				<category domain="organisation">Joliot</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords">FDG;lymphoma;glioblastoma;</category>
				<pubDate>Mon, 08 Oct 2018 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2018/vignette-camera_TEP_CT.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>DNA repair: in-depth look at the initial stages</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2018/DNA-repair-zoom-first-steps.aspx</link>
				<description>A research team from the SB2SM (I2BC@Saclay), in collaboration with the CNRS, SOLEIL , Universities of Paris-Sud, Aix-Marseille and Paul Sabatier - Toulouse III and Gustave Roussy, has resolved structures of two complexes involved in radiation-induced DNA damages. These results were published in Nature Structural &amp; Molecular Biology on October, the 5th.</description>
				<category domain="thematiques">DNA ; Structural biology ; Molecular mechanisms</category>
				<category domain="public"></category>
				<category domain="organisation">SB2SM</category>
				<category domain="typologie">Press release</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 08 Oct 2018 10:00:00 GMT</pubDate>
				<enclosure url="https://www.cea.fr/english/PublishingImages/Pages/News/Radiotherapy-repair-proteins-in-search-of-the-ring-to-protect-DNA/irradiation%20cellules.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>What is the relationship between variants of the BRCA1 gene and susceptibility to cancer?</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2018/relationship-variants-BRCA1-cancer.aspx</link>
				<description>Research Teams from the Curie Institute, the Gustave Roussy Institute, as well as the biophysics teams from the Institute of Chemistry of Natural Substances and SB2SM (I2BC@Saclay) met to systematically identify structural defects and BRCA1 proteins encoded by variants of the BRCA1 gene, a gene predisposing to breast and ovarian cancer. Their results make it possible to propose a classification of these variants (neutral versus causal).</description>
				<category domain="thematiques">Cancer ; Structural biology ; DNA</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Fri, 28 Sep 2018 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2018/Vignette_Zinn_Brca1.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Protein modification: myristoylation finally decoded</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2018/myristoylation-decoded.aspx</link>
				<description>An I2BC Research Team, in collaboration with the ICSN and the Ecole Polytechnique, has mapped for the first time, in man and the model plant Arabidopsis thaliana, the myristoylome, namely the whole proteins modified with a fatty acid, myristate. This modification is important because it targets these proteins to the membranes and thus contributes to their subcellular compartmentalization. These data represent an important resource, available to the community of biologists.</description>
				<category domain="thematiques">Structural biology</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">News</category>
				<category domain="keywords"></category>
				<pubDate>Tue, 26 Jun 2018 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2018/vignette-meinnel.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>Functionalized micellar nanovectors for targeted tumor therapy</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2018/functionalized-micellar-nanovectors.aspx</link>
				<description>​As part of a collaboration with MIRCen (Institute of Biology François Jacob) and SBIGeM, SCBM researchers have developed functional micellar nanovectors capable of targeting a population of cancer cells.
</description>
				<category domain="thematiques">Chemistry ; Cancer</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Thu, 12 Apr 2018 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2018/vignette.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>The ghosts of fluorescence</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2018/ghosts-of-fluorescence.aspx</link>
				<description>Cell biology uses fluorescent labeling, an essential technique to follow the life of the cell. But fluorescent proteins have their limits, which researchers from IBS and I2BC @ Saclay (SB2SM) are trying to repel.</description>
				<category domain="thematiques">Structural biology ; Proteomics</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Wed, 28 Mar 2018 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2018/vignette-klaus-ibs.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>An original biotechnological approach to create new bioactive molecules</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2018/biotechnological-approach-new-bioactive-molecules.aspx</link>
				<description>​Muriel Gondry&apos;s Research Team (I2BC@Saclay / SBIGeM), in collaboration with SIMOPRO and Biomolecules Laboratory of the Sorbonne University&apos;s one, produced 200 cyclodipeptides containing non-natural amino acids by luring and diverting the cellular machinery for the synthesis of proteins. This unprecedented approach significantly increases the diversity of these bioactive molecules.
</description>
				<category domain="thematiques">Biotechnology ; Structural biology</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 05 Mar 2018 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2018/vignette-gondry.png?RenditionID=5" type="image/png"></enclosure>
			</item>

			<item>
				<title>New MOOC on biological crystallography</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Institute/2017/New_MOOC_on_biological_crystallography.aspx</link>
				<description>Paris-Saclay University is pleased to present the MOOC &quot;Journey to the heart of life with X-rays: crystallography&quot;, result of a close collaboration between the Department I2BC @ Saclay (pedagogical director: Marie-Hélène Le Du ), the Sun Synchrotron, the Ecole Polytechnique, the CNRS, and the University Paris Sud.</description>
				<category domain="thematiques">Institutional ; Health ＆ life sciences ; Structural biology</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">News</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 18 Sep 2017 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_institutionnelles/2017/MOOC_cristallo_LEDU.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>[18F] Fludarabine, a hope for lymphoma imaging</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/News/Science_news/2017/fludarabine_hope.aspx</link>
				<description>A Research Team of the SHFJ (LDM-TEP) has just developed an innovative radiopharmaceutical for lymphoproliferative diseases, [18F] Fludarabine.</description>
				<category domain="thematiques">Cancer ; Medical imaging</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 29 May 2017 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2017/camera_TEP_CT.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Pierre Fabre and H-Immune: a strategic research partnership for the development of immunotherapies in the field of cancer.</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Institute/2017/Pierre_fabre_h_immune.aspx</link>
				<description>​After its creation by Michel Léonetti, a researcher at SPI / LERI, and Luc Boblet, external holder at the CEA, backed by the IDEX Paris-Saclay funding among other things, the H-Immune start-up recently signed a partnership agreement with the Pierre Fabre Innovation Fund to develop cancer immunotherapy treatments.
</description>
				<category domain="thematiques">Cancer ; Institutional</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">News</category>
				<category domain="keywords"></category>
				<pubDate>Wed, 03 May 2017 10:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_institutionnelles/2017/Vignette_Leonetti.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Monitoring hadrontherapy to improve patient safety</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/news/Science/2017/Monitoring_hadrontherapy_to_improve_patient_safety.aspx</link>
				<description>Evaluating the biological impact of hadrontherapy in healthy tissue upstream of a tumor is essential to assess the risk of radiation-induced sequelae. In the treatment of bone tumors, healthy articular cartilages are present in the path of the carbon ion beams. The development of 3D models has enabled IRCM&apos;s LARIA Research Team, in collaboration with IRAMIS and IBITECS (SBIGeM), to have relevant evaluation systems for these tissues.</description>
				<category domain="thematiques">Cancer ; Health ＆ life sciences</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 13 Mar 2017 11:00:00 GMT</pubDate>
				<enclosure url="https://joliot.cea.fr/drf/joliot/PublishingImages/Actualites/Actualites/Actualites_scientifiques/2017/cancer-cells-541954_1280.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Micellar nanovectors for tumor imaging.</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/ARCHIVES/IBITECS_anglais/News/2015/Micellar_nanovectors_tumor_imaging.aspx</link>
				<description>In the context of a collaboration with the I²BM institute, researchers from SCBM have designed micellar vectors for targeting and visual delineation of tumors.</description>
				<category domain="thematiques">Nanomedicine ; Cancer</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">News</category>
				<category domain="keywords"></category>
				<pubDate>Tue, 15 Dec 2015 11:00:00 GMT</pubDate>
				<enclosure url="https://www.cea.fr/drf/ibitecs/PublishingImages/Actualites/Actualites/2015/Vignette_micelle_reduit_Doris.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>The catalytic mechanism of cyclodipeptide synthases finally elucidated!</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/ARCHIVES/IBITECS_anglais/News/2015/cyclodipeptide_synthases_elucidated-.aspx</link>
				<description>Teams of IBITECS and Ecole Polytechnique (Palaiseau) have deciphered the mechanism used by the cyclodipeptide synthases (CDPS) to catalyze the formation of peptide bonds.
</description>
				<category domain="thematiques">Structural biology ; Cellular mechanisms</category>
				<category domain="public"></category>
				<category domain="organisation"></category>
				<category domain="typologie">News</category>
				<category domain="keywords"></category>
				<pubDate>Fri, 01 May 2015 10:00:00 GMT</pubDate>
				<enclosure url="https://www.cea.fr/drf/ibitecs/PublishingImages/Services/SIMOPRO/LTMB/vignette_gondry_bis.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>

			<item>
				<title>Lynch Syndrome: structural biology in the service of diagnostic support</title>
				<link>https://www.cea.fr/drf/joliot/en/Pages/ARCHIVES/IBITECS_anglais/News/2013/Lynch-Syndrome-structural-biology-in-the-service-of-diagnostic-support.aspx</link>
				<description>Researchers at the CEA, CNRS and Université Paris-Sud have presented the first model of the architecture of the MLH1 protein associated with Lynch syndrome, a genetic predisposition to colorectal cancer. This atomic level “image” of MLH1 will lead to better understanding of the genetic processes that cause the disease.</description>
				<category domain="thematiques">Structural biology ; Cancer</category>
				<category domain="public"></category>
				<category domain="organisation">IBITECS</category>
				<category domain="typologie">Scientific result</category>
				<category domain="keywords"></category>
				<pubDate>Mon, 25 Feb 2013 11:00:00 GMT</pubDate>
				<enclosure url="https://www.cea.fr/drf/PublishingImages/Actualites/2013/Fevrier/syndrome-de-lynch-la-biologie-structurale-en-soutien-de-l-aide-au-diagnostic_vignette.jpg?RenditionID=5" type="image/jpg"></enclosure>
			</item>
	</channel>
</rss>
